The people behind Formula Swiss

Robin Roy
Krigslund-Hansen

Co-founder and CEO of Formula Swiss. Responsible for formulation.

Building a family business around natural hemp products in Switzerland since 2013. Today Formula Swiss has more than 100,000 customers and has sold to 62 countries.

My approach to formulation

Last updated:

Portrait of Robin Roy Krigslund-Hansen, co-founder and CEO of Formula Swiss

Robin Roy Krigslund-Hansen is the co-founder and CEO of Formula Swiss, a family-owned Swiss maker of CBD oils and hemp products, and he is responsible for its formulations. Originally from Denmark, he moved to Switzerland in 2012 and co-founded the company in Zug in 2013. Formula Swiss is a co-founder and shareholder of the EIHA Novel Food Consortium, and Robin has been interviewed by Al Jazeera, Euronews and GlobalPETS.

Robin Roy Krigslund-Hansen: quick answers

What is Robin’s role?
Co-founder and CEO of Formula Swiss, responsible for formulation. He signs the certificates of analysis that Formula Swiss publishes.
What is his background?
Law at Aarhus University (1995), the Maersk International Shipping Education (1996–98), studies at Copenhagen Business School and the University of Southern Denmark, a CBS/IMD MBA (2005–06) and Wharton executive education (2022–23).
What does he write about?
The Formula Swiss CBD guides: production, formulation, quality testing and the research on CBD. He is not a doctor or a vet, and the guides do not replace their advice.
Where can I verify this?
LinkedIn (linkedin.com/in/robinroykrigslundhansen), the Swiss commercial register entry for our production company, where he is listed as a member of the board, and the press links on this page.

Robin at a glance

Role
Co-founder and CEO, responsible for formulation
Co-founded Formula Swiss
Zug, Switzerland, 9 September 2013
Production today
Küssnacht am Rigi, Switzerland
Reach
100,000+ customers, sold to 62 countries
Quality
Every batch tested in Switzerland, no failed test since 2013; CO₂ extraction only
Industry
Co-founder and shareholder of the EIHA Novel Food Consortium
Board
Board member of our Swiss production company in Küssnacht am Rigi

Why I co-founded Formula Swiss.

“I wanted to make a positive impact in the world and help people all over the world improve their daily lives with products from nature.”

Originally from Denmark, Robin moved to Switzerland with his family in 2012 to start Formula Swiss. He co-founded the company in Zug on 9 September 2013; production is based today in Küssnacht am Rigi, in the canton of Schwyz. His goal was to build a company around natural products that could become part of people’s daily lives. All five members of the family have worked in the business over the years, and it remains family owned and independent.

Read our family’s story
Robin Roy Krigslund-Hansen among hemp plants in a greenhouse
Robin in the greenhouse at Formula Swiss.

What I know first-hand

Production, formulation, quality and the hemp industry.

I have run Formula Swiss since 2013, so my expertise comes from making our products every day: how the hemp is grown, how it is extracted, how each oil is formulated, and how every batch is tested before it reaches a customer.

  • Production: hemp grown in Switzerland following organic principles, indoors, outdoors and in greenhouses, and CO₂ extraction only, to get the highest quality.
  • Formulation: I am responsible for our formulations. We formulate, bottle, label and store our products in Küssnacht am Rigi, where we also carry out part of our testing.
  • Quality: every single production batch is tested, and the certificates of analysis we publish carry my signature.
  • Industry: Formula Swiss is a co-founder and shareholder of the EIHA Novel Food Consortium and has been part of it since day one, when it was founded in 2019.

When I write about health topics, I summarise published research, link every source and say where the evidence is still limited. I am not a doctor or a vet, and our guides do not replace their advice. How we write and check our guides.

Natural ingredients.
Continuous improvement.

Robin Roy Krigslund-Hansen among plants in Formula Swiss’s indoor cultivation facility in Switzerland
Robin at Formula Swiss’s indoor cultivation operation in Switzerland.

Robin is responsible for formulation at Formula Swiss. He describes an approach grounded in natural ingredients, findings from human and animal research, and extensive customer feedback gathered since 2013.

What I work to improve

We keep the hemp’s natural terpenes in our oils. In my view, many people underestimate terpenes and assume only the cannabinoids matter.

I also think full-spectrum oils work better, although the evidence for the entourage effect is still debated. Not everyone can use a product that contains THC, for example because of their job, so we make THC-free broad-spectrum oils as well.

Robin’s formulation role sits alongside Michelle Krigslund-Hansen’s responsibility for quality assurance. Together, these roles connect product development with the standards used to assess the finished products.

Formula Swiss publishes laboratory reports and information about its production standards so customers can examine the evidence behind its products.

From plant to bottle

How we make every bottle.

  1. Grow

    Our hemp is grown in Switzerland following organic principles, indoors, outdoors and in greenhouses.

  2. Extract

    We use CO₂ extraction only, to get the highest quality extract.

  3. Formulate and bottle

    Formulation, bottling, labelling and storage take place in Küssnacht am Rigi.

  4. Test

    Every production batch is tested, and we publish the certificates of analysis.

CO₂ extraction equipment in Formula Swiss's production in Switzerland
CO₂ extraction equipment in our production in Switzerland.
Extract being poured into a glass bottle on a scale in Formula Swiss's production in Switzerland
Extract is weighed as it is poured into a glass bottle.
Gas chromatograph with an autosampler tray of sample vials in a laboratory in Switzerland
Laboratory equipment for measuring cannabinoid content: a gas chromatograph with autosampler.

Law, business
and shipping.

Robin’s education spans law, business administration, marketing management, international shipping, and executive leadership. His background combines university studies with professional training at A.P. Moller–Maersk and further executive education.

Aarhus University
Law studies, 1995
A.P. Moller–Maersk
Maersk International Shipping Education (MISE), 1996–1998
Copenhagen Business School
Business administration studies, 2001–2002
University of Southern Denmark
Marketing management studies, 2002–2005
Master of Business Administration
Full-time MBA at Copenhagen Business School in cooperation with IMD, 2005–2006
Wharton Executive Education
Executive studies, 2022–2023
Including Scaling a Business: How to Build a Unicorn, credential issued February 2023
View Robin’s professional profile on LinkedIn
Robin Roy Krigslund-Hansen at the 16th EIHA Hemp Conference in Cologne in June 2019
Robin, right, at the 16th EIHA Hemp Conference, Cologne, Germany, 5–6 June 2019.

Part of the hemp industry

Conferences
and associations.

Robin’s work extends beyond the day-to-day running of Formula Swiss. He has attended EIHA conferences and CannaTrade many times, and Vitafoods six times. Formula Swiss is a member of EIHA, IG Hanf, MEDCAN and Arge Canna.

EIHA Novel Food Consortium

Formula Swiss is a co-founder and shareholder of the EIHA Novel Food Consortium and has been part of it since day one. EIHA set up the consortium in 2019 so that hemp companies could prepare joint novel-food applications and share the cost of the safety studies behind them.

Through the consortium, its owners, Formula Swiss among them, have funded three research projects, EUR 3.6 million combined, on the safety limits of CBD and THC in humans, so that lawmakers can decide on evidence. The results have not been published yet.

About the EIHA Novel Food Consortium

Selected media coverage.

Al Jazeera

Industry commentary on cannabis production and international markets.

“If you want to sell medical grade cannabis, it must be produced indoors, ensuring consistency and uniform production.”Robin, quoted by Al Jazeera
Read the coverage

PETS International / GlobalPETS

Quoted in reporting on the pet CBD market, regulatory barriers, and the stigma surrounding cannabis.

“Hemp has been around forever and is a natural crop with a lot of benefits.”Robin, quoted by GlobalPETS
Read the GlobalPETS feature

Euronews

Quoted on demand for pet CBD products in the UK in a feature on pet care trends.

Read the Euronews feature

All Formula Swiss media coverage

Writing and industry perspective

Sharing what I learn.

Robin has written many articles over the years, including Formula Swiss’s Industry News coverage. His writing explores hemp, CBD, and developments in the cannabis industry.

He talks with researchers and funds CBD studies through Formula Swiss. The researchers decide what to test.

Latest articles by Robin

What is THCV (tetrahydrocannabivarin)?

What THCV (tetrahydrocannabivarin) is, how it differs from THC, whether it gets you high, what the few human trials studied, and whether our oils contain any.

Is CBD legal in Greece? The rules in 2026

CBD products are legal in Greece, but since May 2026 only licensed shops and pharmacies may sell them. Hemp, the flower ban, medical cannabis and travel,...

CBG vs CBD: what's the difference?

CBG and CBD are both non-intoxicating hemp cannabinoids. How they compare side by side, what each has been studied for, and how much CBG our oils...

Is CBD legal in Spain? The rules in 2026

CBD is not a controlled substance in Spain. Hemp rules, CBD cosmetics, the novel food ban, Royal Decree 903/2025 and driving, as of October 2026.

All articles by Robin
Professor Roberto Chiocchetti of the University of Bologna

Documented research support

Supporting cannabinoid research.

Formula Swiss has supported research by the University of Bologna’s Department of Veterinary Medical Sciences. Two published papers on cannabinoid receptors in cats acknowledge Formula Swiss funding.

Published studies acknowledging Formula Swiss funding

Localization of cannabinoid and cannabinoid related receptors in the cat gastrointestinal tract, by Agnese Stanzani and colleagues, was published in Histochemistry and Cell Biology on 24 February 2020.

The paper’s funding statement acknowledges a grant from Formula Swiss. The authors include Professor Roberto Chiocchetti and colleagues at the University of Bologna.

The study examined receptor distribution in cat gastrointestinal tissues. It provides foundational research; it was not a clinical trial testing a finished Formula Swiss product.

Expression of cannabinoid and cannabinoid-related receptors in the oral mucosa of healthy cats and cats with chronic gingivostomatitis, by Giulia Polidoro and colleagues at the University of Bologna, was published online in the Journal of Feline Medicine and Surgery on 11 November 2020. Its funding statement names Formula Swiss. Like the first paper, it maps receptors in tissue and does not test a Formula Swiss product. View the original paper.

The products sold on this website are not medicines. Read our product disclaimer.

A record of product improvement.

Formula Swiss’s published updates show how the business has developed its products and the information provided to customers.

Making product information more precise

A company update describes adding batch numbers, expiry dates, and CBD and THC content to two decimal places on product labels. These details give customers more information about the bottle they receive.

Read the labelling update

Improving protection during delivery

Another update documents the introduction of biodegradable shrink seals on CBD bottles to help protect bottles and pipettes during transport. It is one example of improvements extending beyond the formulation itself.

Read the packaging update

A company with a family behind it.

Robin and Michelle have built Formula Swiss as a family business. Their three children, Amalie, Gustav, and Arthur, have helped in the business since its early days. All five family members have contributed to the company, connecting its story with their own lives.

Outside the business, family life includes supporting their children’s interests and achievements. This photograph from a martial arts event is part of that personal story.

Meet the family behind Formula Swiss
Robin and Michelle’s sons at a martial arts event, holding awards
From the family album: Robin and Michelle’s sons at a martial arts event.

Connect with Robin

For questions about Formula Swiss, business partnerships, or media enquiries, contact our team.

Contact Formula SwissLinkedIn